FlowCardia: Playing it Safe in Total Occlusions
Executive Summary
Chronic total occlusions remain one of the most significant challenges and opportunities facing interventional cardiologists and radiologists. FlowCardia is looking to succeed where other device companies have failed by emphasizing safety and simplicity.
You may also be interested in...
Challenges & Opportunities for CABG Surgery
Recent safety issues with drug-eluting stents may have opened the door ever so slightly for cardiac surgeons and coronary artery bypass graft (CABG) surgery to stage a small but noticeable comeback in the treatment of coronary artery disease.
In Brief January 2007
A brief summary of recent product developments in the device industry, including updates on Edwards Lifesciences, Cardiophonics, Boston Scientific. Also, short takes on the Pediatric Medical Device Safety and Improvement Act, and Annual Breast Cancer Screening.
Industry Perspective - The Medtech Industry: A Look Back at 2006
The year 2006 may best be remembered for the handful of high-profile companies that struggled, but for all of the challenges that a few medical device companies faced individually, it's hard not to see 2006 as anything other than a robust year for the industry as a whole. It was also a year of impressive rebounds for many other device companies that had faced tough times.